Target
TSP-1
2 abstracts
Abstract
Can targeting TSP-1 with gabapentin enhance survival in glioblastoma? A 20-year retrospective cohort study.Org: University of California, San Francisco, San Francisco, CA, University of California, San Francisco, School of Medicine, San Francisco, CA, Miami Cancer Institute, Miami, FL,
Abstract
Targeting the CD47/TSP-1 axis: A promising strategy for patients with ovarian cancer (OC) that relapses on PARP inhibitors (PARPi).Org: Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Apmonia Therapeutics, CNRS UMR 7369 MEDyC - Reims University,